BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 16775170)

  • 1. Inflammation-related gene polymorphisms and colorectal adenoma.
    Gunter MJ; Canzian F; Landi S; Chanock SJ; Sinha R; Rothman N
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1126-31. PubMed ID: 16775170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trial.
    Sansbury LB; Bergen AW; Wanke KL; Yu B; Caporaso NE; Chatterjee N; Ratnasinghe L; Schatzkin A; Lehman TA; Kalidindi A; Modali R; Lanza E
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):494-501. PubMed ID: 16537707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps.
    Ulrich CM; Bigler J; Sparks R; Whitton J; Sibert JG; Goode EL; Yasui Y; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):889-93. PubMed ID: 15159324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
    Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps.
    Poole EM; Bigler J; Whitton J; Sibert JG; Potter JD; Ulrich CM
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):502-8. PubMed ID: 16537708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland.
    Macarthur M; Sharp L; Hold GL; Little J; El-Omar EM
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1613-8. PubMed ID: 16030091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.
    Potter JD; Bigler J; Fosdick L; Bostick RM; Kampman E; Chen C; Louis TA; Grambsch P
    Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):69-75. PubMed ID: 9950242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
    Tan XL; Nieters A; Hoffmeister M; Beckmann L; Brenner H; Chang-Claude J
    Pharmacogenet Genomics; 2007 Aug; 17(8):639-45. PubMed ID: 17622940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer.
    Landi S; Moreno V; Gioia-Patricola L; Guino E; Navarro M; de Oca J; Capella G; Canzian F;
    Cancer Res; 2003 Jul; 63(13):3560-6. PubMed ID: 12839942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin promoter polymorphisms and prognosis in colorectal cancer.
    Wilkening S; Tavelin B; Canzian F; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P; Försti A
    Carcinogenesis; 2008 Jun; 29(6):1202-6. PubMed ID: 18448485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential?
    Morimoto LM; Newcomb PA; Ulrich CM; Bostick RM; Lais CJ; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1012-8. PubMed ID: 12376501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGFbeta1 polymorphism (L10P) and risk of colorectal adenomatous and hyperplastic polyps.
    Sparks R; Bigler J; Sibert JG; Potter JD; Yasui Y; Ulrich CM
    Int J Epidemiol; 2004 Oct; 33(5):955-61. PubMed ID: 15020570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methyltransferase and alcohol dehydrogenase: gene-nutrient interactions in relation to risk of colorectal polyps.
    Jung AY; Poole EM; Bigler J; Whitton J; Potter JD; Ulrich CM
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):330-8. PubMed ID: 18268116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance-related genes and advanced left-sided colorectal adenoma.
    Gunter MJ; Hayes RB; Chatterjee N; Yeager M; Welch R; Schoen RE; Yakochi L; Schatzkin A; Peters U
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):703-8. PubMed ID: 17416760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium, vitamin D, and risk for colorectal adenoma: dependency on vitamin D receptor BsmI polymorphism and nonsteroidal anti-inflammatory drug use?
    Boyapati SM; Bostick RM; McGlynn KA; Fina MF; Roufail WM; Geisinger KR; Wargovich M; Coker A; Hebert JR
    Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):631-7. PubMed ID: 12869402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia.
    Ennas MG; Moore PS; Zucca M; Angelucci E; Cabras MG; Melis M; Gabbas A; Serpe R; Madeddu C; Scarpa A; Cocco P
    Hematol Oncol; 2008 Jun; 26(2):98-103. PubMed ID: 18271063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of cyclooxygenase-2 and colorectal adenoma risk: the Self Defense Forces Health Study.
    Ueda N; Maehara Y; Tajima O; Tabata S; Wakabayashi K; Kono S
    Cancer Sci; 2008 Mar; 99(3):576-81. PubMed ID: 18167131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study.
    Vogel U; Christensen J; Wallin H; Friis S; Nexø BA; Raaschou-Nielsen O; Overvad K; Tjønneland A
    Mutat Res; 2008 Mar; 639(1-2):89-100. PubMed ID: 18164040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common polymorphisms in 5-lipoxygenase and 12-lipoxygenase genes and the risk of incident, sporadic colorectal adenoma.
    Gong Z; Hebert JR; Bostick RM; Deng Z; Hurley TG; Dixon DA; Nitcheva D; Xie D
    Cancer; 2007 Mar; 109(5):849-57. PubMed ID: 17236225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk.
    Bigler J; Whitton J; Lampe JW; Fosdick L; Bostick RM; Potter JD
    Cancer Res; 2001 May; 61(9):3566-9. PubMed ID: 11325819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.